594 related articles for article (PubMed ID: 30221596)
21. Role of Aspirin for Primary Prevention in Persons with Diabetes Mellitus and in the Elderly.
Patel NJ; Baliga RR
Curr Cardiol Rep; 2020 May; 22(7):48. PubMed ID: 32472363
[TBL] [Abstract][Full Text] [Related]
22. Effect of Aspirin on Activities of Daily Living Disability in Community-Dwelling Older Adults.
Woods RL; Espinoza S; Thao LTP; Ernst ME; Ryan J; Wolfe R; Shah RC; Ward SA; Storey E; Nelson MR; Reid CM; Lockery JE; Orchard SG; Trevaks RE; Fitzgerald SM; Stocks NP; Williamson JD; McNeil JJ; Murray AM; Newman AB
J Gerontol A Biol Sci Med Sci; 2021 Oct; 76(11):2007-2014. PubMed ID: 33367621
[TBL] [Abstract][Full Text] [Related]
23. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke.
; Benavente OR; Hart RG; McClure LA; Szychowski JM; Coffey CS; Pearce LA
N Engl J Med; 2012 Aug; 367(9):817-25. PubMed ID: 22931315
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial.
Sleem A; Effron MB; Stebbins A; Wruck LM; Marquis-Gravel G; Muñoz D; Re RN; Gupta K; Pepine CJ; Jain SK; Girotra S; Whittle J; Benziger CP; Farrehi PM; Knowlton KU; Polonsky TS; Roe MT; Rothman RL; Harrington RA; Jones WS; Hernandez AF
JAMA Cardiol; 2023 Nov; 8(11):1061-1069. PubMed ID: 37792369
[TBL] [Abstract][Full Text] [Related]
25. Effect of clopidogrel added to aspirin in patients with atrial fibrillation.
; Connolly SJ; Pogue J; Hart RG; Hohnloser SH; Pfeffer M; Chrolavicius S; Yusuf S
N Engl J Med; 2009 May; 360(20):2066-78. PubMed ID: 19336502
[TBL] [Abstract][Full Text] [Related]
26. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.
Bhatt DL; Fox KA; Hacke W; Berger PB; Black HR; Boden WE; Cacoub P; Cohen EA; Creager MA; Easton JD; Flather MD; Haffner SM; Hamm CW; Hankey GJ; Johnston SC; Mak KH; Mas JL; Montalescot G; Pearson TA; Steg PG; Steinhubl SR; Weber MA; Brennan DM; Fabry-Ribaudo L; Booth J; Topol EJ;
N Engl J Med; 2006 Apr; 354(16):1706-17. PubMed ID: 16531616
[TBL] [Abstract][Full Text] [Related]
27. The Effect of Low-Dose Aspirin on Frailty Phenotype and Frailty Index in Community-Dwelling Older Adults in the ASPirin in Reducing Events in the Elderly Study.
Espinoza SE; Woods RL; Ekram ARMS; Ernst ME; Polekhina G; Wolfe R; Shah RC; Ward SA; Storey E; Nelson MR; Reid CM; Lockery JE; Orchard SG; Trevaks R; Fitzgerald SM; Stocks NP; Chan A; McNeil JJ; Murray AM; Newman AB; Ryan J
J Gerontol A Biol Sci Med Sci; 2022 Oct; 77(10):2007-2014. PubMed ID: 34758073
[TBL] [Abstract][Full Text] [Related]
28. Effect of aspirin on deaths associated with sepsis in healthy older people (ANTISEPSIS): a randomised, double-blind, placebo-controlled primary prevention trial.
Eisen DP; Leder K; Woods RL; Lockery JE; McGuinness SL; Wolfe R; Pilcher D; Moore EM; Shastry A; Nelson MR; Reid CM; McNeil JJ; McBryde ES
Lancet Respir Med; 2021 Feb; 9(2):186-195. PubMed ID: 32950072
[TBL] [Abstract][Full Text] [Related]
29. Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA.
Johnston SC; Amarenco P; Denison H; Evans SR; Himmelmann A; James S; Knutsson M; Ladenvall P; Molina CA; Wang Y;
N Engl J Med; 2020 Jul; 383(3):207-217. PubMed ID: 32668111
[TBL] [Abstract][Full Text] [Related]
30. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
Ikeda Y; Shimada K; Teramoto T; Uchiyama S; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Ishizuka N
JAMA; 2014 Dec; 312(23):2510-20. PubMed ID: 25401325
[TBL] [Abstract][Full Text] [Related]
31. Association of Statin Use With Disability-Free Survival and Cardiovascular Disease Among Healthy Older Adults.
Zhou Z; Ofori-Asenso R; Curtis AJ; Breslin M; Wolfe R; McNeil JJ; Murray AM; Ernst ME; Reid CM; Lockery JE; Woods RL; Tonkin AM; Nelson MR
J Am Coll Cardiol; 2020 Jul; 76(1):17-27. PubMed ID: 32616158
[TBL] [Abstract][Full Text] [Related]
32. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
[TBL] [Abstract][Full Text] [Related]
33. Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation.
Brouwer J; Nijenhuis VJ; Delewi R; Hermanides RS; Holvoet W; Dubois CLF; Frambach P; De Bruyne B; van Houwelingen GK; Van Der Heyden JAS; Toušek P; van der Kley F; Buysschaert I; Schotborgh CE; Ferdinande B; van der Harst P; Roosen J; Peper J; Thielen FWF; Veenstra L; Chan Pin Yin DRPP; Swaans MJ; Rensing BJWM; van 't Hof AWJ; Timmers L; Kelder JC; Stella PR; Baan J; Ten Berg JM
N Engl J Med; 2020 Oct; 383(15):1447-1457. PubMed ID: 32865376
[TBL] [Abstract][Full Text] [Related]
34. Prescription Medication Use in Older Adults Without Major Cardiovascular Disease Enrolled in the Aspirin in Reducing Events in the Elderly (ASPREE) Clinical Trial.
Lockery JE; Ernst ME; Broder JC; Orchard SG; Murray A; Nelson MR; Stocks NP; Wolfe R; Reid CM; Liew D; Woods RL;
Pharmacotherapy; 2020 Oct; 40(10):1042-1053. PubMed ID: 33078479
[TBL] [Abstract][Full Text] [Related]
35. The aspirin in reducing events in the elderly trial: Statistical analysis plan.
Wolfe R; Murray AM; Woods RL; Kirpach B; Gilbertson D; Shah RC; Nelson MR; Reid CM; Ernst ME; Lockery J; Donnan GA; Williamson J; McNeil JJ
Int J Stroke; 2018 Apr; 13(3):335-338. PubMed ID: 29111960
[TBL] [Abstract][Full Text] [Related]
36. Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney disease.
Wolfe R; Wetmore JB; Woods RL; McNeil JJ; Gallagher H; Roderick P; Walker R; Nelson MR; Reid CM; Shah RC; Ernst ME; Lockery JE; Tonkin AM; Abhayaratna WP; Gibbs P; Wood EM; Mahady SE; Williamson JD; Donnan GA; Cloud GC; Murray AM; Polkinghorne KR
Kidney Int; 2021 Feb; 99(2):466-474. PubMed ID: 32920022
[TBL] [Abstract][Full Text] [Related]
37. Low-Dose Aspirin and the Risk of Stroke and Intracerebral Bleeding in Healthy Older People: Secondary Analysis of a Randomized Clinical Trial.
Cloud GC; Williamson JD; Thao LTP; Tran C; Eaton CB; Wolfe R; Nelson MR; Reid CM; Newman AB; Lockery J; Fitzgerald SM; Murray AM; Shah RC; Woods RL; Donnan GA; McNeil JJ
JAMA Netw Open; 2023 Jul; 6(7):e2325803. PubMed ID: 37494038
[TBL] [Abstract][Full Text] [Related]
38. A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.
Dangas GD; Tijssen JGP; Wöhrle J; Søndergaard L; Gilard M; Möllmann H; Makkar RR; Herrmann HC; Giustino G; Baldus S; De Backer O; Guimarães AHC; Gullestad L; Kini A; von Lewinski D; Mack M; Moreno R; Schäfer U; Seeger J; Tchétché D; Thomitzek K; Valgimigli M; Vranckx P; Welsh RC; Wildgoose P; Volkl AA; Zazula A; van Amsterdam RGM; Mehran R; Windecker S;
N Engl J Med; 2020 Jan; 382(2):120-129. PubMed ID: 31733180
[TBL] [Abstract][Full Text] [Related]
39. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework.
Lancet; 1998 Jan; 351(9098):233-41. PubMed ID: 9457092
[TBL] [Abstract][Full Text] [Related]
40. Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease.
Topol EJ; Easton D; Harrington RA; Amarenco P; Califf RM; Graffagnino C; Davis S; Diener HC; Ferguson J; Fitzgerald D; Granett J; Shuaib A; Koudstaal PJ; Theroux P; Van de Werf F; Sigmon K; Pieper K; Vallee M; Willerson JT;
Circulation; 2003 Jul; 108(4):399-406. PubMed ID: 12874182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
